nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—CYP3A4—Rivastigmine—Alzheimer's disease	0.105	0.432	CbGbCtD
Vardenafil—CYP3A4—Donepezil—Alzheimer's disease	0.0836	0.345	CbGbCtD
Vardenafil—CYP3A4—Galantamine—Alzheimer's disease	0.0539	0.223	CbGbCtD
Vardenafil—PDE6H—forebrain—Alzheimer's disease	0.0123	0.0972	CbGeAlD
Vardenafil—PDE5A—blood vessel—Alzheimer's disease	0.00884	0.0701	CbGeAlD
Vardenafil—PDE10A—forebrain—Alzheimer's disease	0.00797	0.0632	CbGeAlD
Vardenafil—PDE1B—forebrain—Alzheimer's disease	0.0079	0.0626	CbGeAlD
Vardenafil—PDE10A—telencephalon—Alzheimer's disease	0.00733	0.0581	CbGeAlD
Vardenafil—PDE1B—telencephalon—Alzheimer's disease	0.00727	0.0576	CbGeAlD
Vardenafil—PDE6H—nervous system—Alzheimer's disease	0.00666	0.0527	CbGeAlD
Vardenafil—PDE6H—central nervous system—Alzheimer's disease	0.00641	0.0508	CbGeAlD
Vardenafil—PDE6H—brain—Alzheimer's disease	0.00509	0.0403	CbGeAlD
Vardenafil—PDE11A—brain—Alzheimer's disease	0.00509	0.0403	CbGeAlD
Vardenafil—PDE5A—forebrain—Alzheimer's disease	0.00467	0.037	CbGeAlD
Vardenafil—PDE10A—nervous system—Alzheimer's disease	0.00433	0.0343	CbGeAlD
Vardenafil—PDE5A—telencephalon—Alzheimer's disease	0.00429	0.034	CbGeAlD
Vardenafil—PDE1B—nervous system—Alzheimer's disease	0.00429	0.034	CbGeAlD
Vardenafil—PDE10A—central nervous system—Alzheimer's disease	0.00417	0.033	CbGeAlD
Vardenafil—PDE1B—central nervous system—Alzheimer's disease	0.00413	0.0327	CbGeAlD
Vardenafil—PDE10A—cerebellum—Alzheimer's disease	0.00407	0.0323	CbGeAlD
Vardenafil—PDE1B—cerebellum—Alzheimer's disease	0.00404	0.032	CbGeAlD
Vardenafil—PDE10A—brain—Alzheimer's disease	0.00331	0.0262	CbGeAlD
Vardenafil—PDE1B—brain—Alzheimer's disease	0.00328	0.026	CbGeAlD
Vardenafil—PDE5A—nervous system—Alzheimer's disease	0.00253	0.0201	CbGeAlD
Vardenafil—PDE5A—central nervous system—Alzheimer's disease	0.00244	0.0193	CbGeAlD
Vardenafil—PDE5A—cerebellum—Alzheimer's disease	0.00238	0.0189	CbGeAlD
Vardenafil—PDE5A—brain—Alzheimer's disease	0.00194	0.0153	CbGeAlD
Vardenafil—Gastritis—Rivastigmine—Alzheimer's disease	0.00124	0.003	CcSEcCtD
Vardenafil—Influenza—Memantine—Alzheimer's disease	0.00124	0.00299	CcSEcCtD
Vardenafil—Dysphagia—Memantine—Alzheimer's disease	0.00124	0.00299	CcSEcCtD
Vardenafil—Mental disorder—Galantamine—Alzheimer's disease	0.00124	0.00298	CcSEcCtD
Vardenafil—Infestation—Donepezil—Alzheimer's disease	0.00122	0.00294	CcSEcCtD
Vardenafil—Infestation NOS—Donepezil—Alzheimer's disease	0.00122	0.00294	CcSEcCtD
Vardenafil—Dysphagia—Rivastigmine—Alzheimer's disease	0.00121	0.00293	CcSEcCtD
Vardenafil—Angina pectoris—Memantine—Alzheimer's disease	0.00121	0.00292	CcSEcCtD
Vardenafil—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.0012	0.0029	CcSEcCtD
Vardenafil—Myocardial infarction—Donepezil—Alzheimer's disease	0.00119	0.00288	CcSEcCtD
Vardenafil—Back pain—Galantamine—Alzheimer's disease	0.00119	0.00287	CcSEcCtD
Vardenafil—Conjunctivitis—Donepezil—Alzheimer's disease	0.00118	0.00286	CcSEcCtD
Vardenafil—Angina pectoris—Rivastigmine—Alzheimer's disease	0.00118	0.00285	CcSEcCtD
Vardenafil—Muscle spasms—Galantamine—Alzheimer's disease	0.00118	0.00285	CcSEcCtD
Vardenafil—Sweating—Donepezil—Alzheimer's disease	0.00117	0.00282	CcSEcCtD
Vardenafil—Haematuria—Donepezil—Alzheimer's disease	0.00116	0.0028	CcSEcCtD
Vardenafil—Vision blurred—Galantamine—Alzheimer's disease	0.00116	0.00279	CcSEcCtD
Vardenafil—Epistaxis—Donepezil—Alzheimer's disease	0.00115	0.00277	CcSEcCtD
Vardenafil—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00114	0.00275	CcSEcCtD
Vardenafil—Malaise—Galantamine—Alzheimer's disease	0.00111	0.00267	CcSEcCtD
Vardenafil—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.00111	0.00267	CcSEcCtD
Vardenafil—Infestation—Memantine—Alzheimer's disease	0.00111	0.00267	CcSEcCtD
Vardenafil—Infestation NOS—Memantine—Alzheimer's disease	0.00111	0.00267	CcSEcCtD
Vardenafil—Vertigo—Galantamine—Alzheimer's disease	0.0011	0.00266	CcSEcCtD
Vardenafil—Syncope—Galantamine—Alzheimer's disease	0.0011	0.00266	CcSEcCtD
Vardenafil—Haemoglobin—Donepezil—Alzheimer's disease	0.0011	0.00265	CcSEcCtD
Vardenafil—Rhinitis—Donepezil—Alzheimer's disease	0.0011	0.00265	CcSEcCtD
Vardenafil—Haemorrhage—Donepezil—Alzheimer's disease	0.00109	0.00264	CcSEcCtD
Vardenafil—Acute coronary syndrome—Memantine—Alzheimer's disease	0.00109	0.00263	CcSEcCtD
Vardenafil—Hypoaesthesia—Donepezil—Alzheimer's disease	0.00109	0.00263	CcSEcCtD
Vardenafil—Palpitations—Galantamine—Alzheimer's disease	0.00109	0.00262	CcSEcCtD
Vardenafil—Pharyngitis—Donepezil—Alzheimer's disease	0.00109	0.00262	CcSEcCtD
Vardenafil—Myocardial infarction—Memantine—Alzheimer's disease	0.00108	0.00262	CcSEcCtD
Vardenafil—Infestation NOS—Rivastigmine—Alzheimer's disease	0.00108	0.00261	CcSEcCtD
Vardenafil—Infestation—Rivastigmine—Alzheimer's disease	0.00108	0.00261	CcSEcCtD
Vardenafil—Urinary tract disorder—Donepezil—Alzheimer's disease	0.00108	0.00261	CcSEcCtD
Vardenafil—Loss of consciousness—Galantamine—Alzheimer's disease	0.00108	0.00261	CcSEcCtD
Vardenafil—Conjunctivitis—Memantine—Alzheimer's disease	0.00108	0.00259	CcSEcCtD
Vardenafil—Urethral disorder—Donepezil—Alzheimer's disease	0.00107	0.00259	CcSEcCtD
Vardenafil—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.00107	0.00257	CcSEcCtD
Vardenafil—Convulsion—Galantamine—Alzheimer's disease	0.00106	0.00257	CcSEcCtD
Vardenafil—Sildenafil—CYP2D6—Alzheimer's disease	0.00106	1	CrCbGaD
Vardenafil—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.00106	0.00256	CcSEcCtD
Vardenafil—Haematuria—Memantine—Alzheimer's disease	0.00105	0.00254	CcSEcCtD
Vardenafil—Visual impairment—Donepezil—Alzheimer's disease	0.00105	0.00254	CcSEcCtD
Vardenafil—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.00105	0.00254	CcSEcCtD
Vardenafil—Hepatobiliary disease—Memantine—Alzheimer's disease	0.00105	0.00252	CcSEcCtD
Vardenafil—Chest pain—Galantamine—Alzheimer's disease	0.00105	0.00252	CcSEcCtD
Vardenafil—Arthralgia—Galantamine—Alzheimer's disease	0.00105	0.00252	CcSEcCtD
Vardenafil—Myalgia—Galantamine—Alzheimer's disease	0.00105	0.00252	CcSEcCtD
Vardenafil—Epistaxis—Memantine—Alzheimer's disease	0.00104	0.00252	CcSEcCtD
Vardenafil—Anxiety—Galantamine—Alzheimer's disease	0.00104	0.00251	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00104	0.00251	CcSEcCtD
Vardenafil—Sinusitis—Memantine—Alzheimer's disease	0.00104	0.0025	CcSEcCtD
Vardenafil—Sweating—Rivastigmine—Alzheimer's disease	0.00104	0.0025	CcSEcCtD
Vardenafil—Discomfort—Galantamine—Alzheimer's disease	0.00103	0.00249	CcSEcCtD
Vardenafil—Haematuria—Rivastigmine—Alzheimer's disease	0.00103	0.00249	CcSEcCtD
Vardenafil—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.00102	0.00247	CcSEcCtD
Vardenafil—Dry mouth—Galantamine—Alzheimer's disease	0.00102	0.00247	CcSEcCtD
Vardenafil—Epistaxis—Rivastigmine—Alzheimer's disease	0.00102	0.00246	CcSEcCtD
Vardenafil—Tinnitus—Donepezil—Alzheimer's disease	0.00102	0.00246	CcSEcCtD
Vardenafil—Sinusitis—Rivastigmine—Alzheimer's disease	0.00102	0.00245	CcSEcCtD
Vardenafil—Haemoglobin—Memantine—Alzheimer's disease	0.000998	0.00241	CcSEcCtD
Vardenafil—Rhinitis—Memantine—Alzheimer's disease	0.000996	0.0024	CcSEcCtD
Vardenafil—Haemorrhage—Memantine—Alzheimer's disease	0.000993	0.0024	CcSEcCtD
Vardenafil—Hypoaesthesia—Memantine—Alzheimer's disease	0.000988	0.00238	CcSEcCtD
Vardenafil—Shock—Galantamine—Alzheimer's disease	0.000987	0.00238	CcSEcCtD
Vardenafil—Pharyngitis—Memantine—Alzheimer's disease	0.000986	0.00238	CcSEcCtD
Vardenafil—Nervous system disorder—Galantamine—Alzheimer's disease	0.000983	0.00237	CcSEcCtD
Vardenafil—Urinary tract disorder—Memantine—Alzheimer's disease	0.000981	0.00237	CcSEcCtD
Vardenafil—Tachycardia—Galantamine—Alzheimer's disease	0.000979	0.00236	CcSEcCtD
Vardenafil—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000976	0.00236	CcSEcCtD
Vardenafil—Connective tissue disorder—Memantine—Alzheimer's disease	0.000976	0.00235	CcSEcCtD
Vardenafil—Rhinitis—Rivastigmine—Alzheimer's disease	0.000974	0.00235	CcSEcCtD
Vardenafil—Skin disorder—Galantamine—Alzheimer's disease	0.000974	0.00235	CcSEcCtD
Vardenafil—Urethral disorder—Memantine—Alzheimer's disease	0.000974	0.00235	CcSEcCtD
Vardenafil—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000972	0.00234	CcSEcCtD
Vardenafil—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000969	0.00234	CcSEcCtD
Vardenafil—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000967	0.00233	CcSEcCtD
Vardenafil—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000964	0.00233	CcSEcCtD
Vardenafil—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000959	0.00231	CcSEcCtD
Vardenafil—Mental disorder—Donepezil—Alzheimer's disease	0.000958	0.00231	CcSEcCtD
Vardenafil—Visual impairment—Memantine—Alzheimer's disease	0.000957	0.00231	CcSEcCtD
Vardenafil—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000955	0.0023	CcSEcCtD
Vardenafil—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000952	0.0023	CcSEcCtD
Vardenafil—Erythema—Donepezil—Alzheimer's disease	0.000952	0.0023	CcSEcCtD
Vardenafil—Hypotension—Galantamine—Alzheimer's disease	0.000937	0.00226	CcSEcCtD
Vardenafil—Visual impairment—Rivastigmine—Alzheimer's disease	0.000936	0.00226	CcSEcCtD
Vardenafil—Eye disorder—Memantine—Alzheimer's disease	0.000928	0.00224	CcSEcCtD
Vardenafil—Tinnitus—Memantine—Alzheimer's disease	0.000926	0.00223	CcSEcCtD
Vardenafil—Cardiac disorder—Memantine—Alzheimer's disease	0.000922	0.00222	CcSEcCtD
Vardenafil—Flushing—Memantine—Alzheimer's disease	0.000922	0.00222	CcSEcCtD
Vardenafil—Back pain—Donepezil—Alzheimer's disease	0.000921	0.00222	CcSEcCtD
Vardenafil—Muscle spasms—Donepezil—Alzheimer's disease	0.000915	0.00221	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000914	0.0022	CcSEcCtD
Vardenafil—Eye disorder—Rivastigmine—Alzheimer's disease	0.000908	0.00219	CcSEcCtD
Vardenafil—Insomnia—Galantamine—Alzheimer's disease	0.000907	0.00219	CcSEcCtD
Vardenafil—Tinnitus—Rivastigmine—Alzheimer's disease	0.000906	0.00219	CcSEcCtD
Vardenafil—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000902	0.00218	CcSEcCtD
Vardenafil—Flushing—Rivastigmine—Alzheimer's disease	0.000902	0.00218	CcSEcCtD
Vardenafil—Angiopathy—Memantine—Alzheimer's disease	0.000901	0.00217	CcSEcCtD
Vardenafil—Paraesthesia—Galantamine—Alzheimer's disease	0.0009	0.00217	CcSEcCtD
Vardenafil—Vision blurred—Donepezil—Alzheimer's disease	0.000897	0.00216	CcSEcCtD
Vardenafil—Immune system disorder—Memantine—Alzheimer's disease	0.000897	0.00216	CcSEcCtD
Vardenafil—Mediastinal disorder—Memantine—Alzheimer's disease	0.000895	0.00216	CcSEcCtD
Vardenafil—Somnolence—Galantamine—Alzheimer's disease	0.000891	0.00215	CcSEcCtD
Vardenafil—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000883	0.00213	CcSEcCtD
Vardenafil—Dyspepsia—Galantamine—Alzheimer's disease	0.000883	0.00213	CcSEcCtD
Vardenafil—Angiopathy—Rivastigmine—Alzheimer's disease	0.000881	0.00213	CcSEcCtD
Vardenafil—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000876	0.00211	CcSEcCtD
Vardenafil—Mental disorder—Memantine—Alzheimer's disease	0.00087	0.0021	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000866	0.00209	CcSEcCtD
Vardenafil—Malaise—Donepezil—Alzheimer's disease	0.000859	0.00207	CcSEcCtD
Vardenafil—Vertigo—Donepezil—Alzheimer's disease	0.000855	0.00206	CcSEcCtD
Vardenafil—Syncope—Donepezil—Alzheimer's disease	0.000854	0.00206	CcSEcCtD
Vardenafil—Mental disorder—Rivastigmine—Alzheimer's disease	0.000851	0.00205	CcSEcCtD
Vardenafil—Erythema—Rivastigmine—Alzheimer's disease	0.000846	0.00204	CcSEcCtD
Vardenafil—Loss of consciousness—Donepezil—Alzheimer's disease	0.000837	0.00202	CcSEcCtD
Vardenafil—Back pain—Memantine—Alzheimer's disease	0.000836	0.00202	CcSEcCtD
Vardenafil—Feeling abnormal—Galantamine—Alzheimer's disease	0.000826	0.00199	CcSEcCtD
Vardenafil—Convulsion—Donepezil—Alzheimer's disease	0.000825	0.00199	CcSEcCtD
Vardenafil—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00082	0.00198	CcSEcCtD
Vardenafil—Back pain—Rivastigmine—Alzheimer's disease	0.000818	0.00197	CcSEcCtD
Vardenafil—Vision blurred—Memantine—Alzheimer's disease	0.000815	0.00197	CcSEcCtD
Vardenafil—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000813	0.00196	CcSEcCtD
Vardenafil—Chest pain—Donepezil—Alzheimer's disease	0.000811	0.00196	CcSEcCtD
Vardenafil—Myalgia—Donepezil—Alzheimer's disease	0.000811	0.00196	CcSEcCtD
Vardenafil—Arthralgia—Donepezil—Alzheimer's disease	0.000811	0.00196	CcSEcCtD
Vardenafil—Anxiety—Donepezil—Alzheimer's disease	0.000808	0.00195	CcSEcCtD
Vardenafil—Ill-defined disorder—Memantine—Alzheimer's disease	0.000802	0.00194	CcSEcCtD
Vardenafil—Discomfort—Donepezil—Alzheimer's disease	0.000801	0.00193	CcSEcCtD
Vardenafil—Vision blurred—Rivastigmine—Alzheimer's disease	0.000797	0.00192	CcSEcCtD
Vardenafil—Dry mouth—Donepezil—Alzheimer's disease	0.000793	0.00191	CcSEcCtD
Vardenafil—Abdominal pain—Galantamine—Alzheimer's disease	0.000793	0.00191	CcSEcCtD
Vardenafil—CYP3A4—nervous system—Alzheimer's disease	0.00079	0.00626	CbGeAlD
Vardenafil—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000785	0.00189	CcSEcCtD
Vardenafil—Malaise—Memantine—Alzheimer's disease	0.00078	0.00188	CcSEcCtD
Vardenafil—Vertigo—Memantine—Alzheimer's disease	0.000777	0.00187	CcSEcCtD
Vardenafil—Syncope—Memantine—Alzheimer's disease	0.000775	0.00187	CcSEcCtD
Vardenafil—Infection—Donepezil—Alzheimer's disease	0.000772	0.00186	CcSEcCtD
Vardenafil—Shock—Donepezil—Alzheimer's disease	0.000765	0.00184	CcSEcCtD
Vardenafil—Palpitations—Memantine—Alzheimer's disease	0.000764	0.00184	CcSEcCtD
Vardenafil—Malaise—Rivastigmine—Alzheimer's disease	0.000763	0.00184	CcSEcCtD
Vardenafil—Nervous system disorder—Donepezil—Alzheimer's disease	0.000762	0.00184	CcSEcCtD
Vardenafil—CYP3A4—central nervous system—Alzheimer's disease	0.00076	0.00602	CbGeAlD
Vardenafil—Vertigo—Rivastigmine—Alzheimer's disease	0.00076	0.00183	CcSEcCtD
Vardenafil—Loss of consciousness—Memantine—Alzheimer's disease	0.00076	0.00183	CcSEcCtD
Vardenafil—Syncope—Rivastigmine—Alzheimer's disease	0.000758	0.00183	CcSEcCtD
Vardenafil—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000751	0.00181	CcSEcCtD
Vardenafil—Convulsion—Memantine—Alzheimer's disease	0.000749	0.00181	CcSEcCtD
Vardenafil—Palpitations—Rivastigmine—Alzheimer's disease	0.000747	0.0018	CcSEcCtD
Vardenafil—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000743	0.00179	CcSEcCtD
Vardenafil—Hypersensitivity—Galantamine—Alzheimer's disease	0.000739	0.00178	CcSEcCtD
Vardenafil—Chest pain—Memantine—Alzheimer's disease	0.000736	0.00178	CcSEcCtD
Vardenafil—Myalgia—Memantine—Alzheimer's disease	0.000736	0.00178	CcSEcCtD
Vardenafil—Arthralgia—Memantine—Alzheimer's disease	0.000736	0.00178	CcSEcCtD
Vardenafil—Anxiety—Memantine—Alzheimer's disease	0.000733	0.00177	CcSEcCtD
Vardenafil—Convulsion—Rivastigmine—Alzheimer's disease	0.000733	0.00177	CcSEcCtD
Vardenafil—Discomfort—Memantine—Alzheimer's disease	0.000727	0.00175	CcSEcCtD
Vardenafil—Hypotension—Donepezil—Alzheimer's disease	0.000726	0.00175	CcSEcCtD
Vardenafil—Myalgia—Rivastigmine—Alzheimer's disease	0.00072	0.00174	CcSEcCtD
Vardenafil—Arthralgia—Rivastigmine—Alzheimer's disease	0.00072	0.00174	CcSEcCtD
Vardenafil—Chest pain—Rivastigmine—Alzheimer's disease	0.00072	0.00174	CcSEcCtD
Vardenafil—Dry mouth—Memantine—Alzheimer's disease	0.00072	0.00174	CcSEcCtD
Vardenafil—Asthenia—Galantamine—Alzheimer's disease	0.000719	0.00174	CcSEcCtD
Vardenafil—Anxiety—Rivastigmine—Alzheimer's disease	0.000718	0.00173	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000715	0.00173	CcSEcCtD
Vardenafil—Discomfort—Rivastigmine—Alzheimer's disease	0.000711	0.00172	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000708	0.00171	CcSEcCtD
Vardenafil—Dry mouth—Rivastigmine—Alzheimer's disease	0.000704	0.0017	CcSEcCtD
Vardenafil—Insomnia—Donepezil—Alzheimer's disease	0.000703	0.0017	CcSEcCtD
Vardenafil—Infection—Memantine—Alzheimer's disease	0.000701	0.00169	CcSEcCtD
Vardenafil—Paraesthesia—Donepezil—Alzheimer's disease	0.000698	0.00168	CcSEcCtD
Vardenafil—Shock—Memantine—Alzheimer's disease	0.000694	0.00167	CcSEcCtD
Vardenafil—Dyspnoea—Donepezil—Alzheimer's disease	0.000693	0.00167	CcSEcCtD
Vardenafil—Nervous system disorder—Memantine—Alzheimer's disease	0.000692	0.00167	CcSEcCtD
Vardenafil—Somnolence—Donepezil—Alzheimer's disease	0.000691	0.00167	CcSEcCtD
Vardenafil—Tachycardia—Memantine—Alzheimer's disease	0.000689	0.00166	CcSEcCtD
Vardenafil—Diarrhoea—Galantamine—Alzheimer's disease	0.000686	0.00166	CcSEcCtD
Vardenafil—Infection—Rivastigmine—Alzheimer's disease	0.000686	0.00165	CcSEcCtD
Vardenafil—Skin disorder—Memantine—Alzheimer's disease	0.000685	0.00165	CcSEcCtD
Vardenafil—Dyspepsia—Donepezil—Alzheimer's disease	0.000684	0.00165	CcSEcCtD
Vardenafil—Hyperhidrosis—Memantine—Alzheimer's disease	0.000682	0.00165	CcSEcCtD
Vardenafil—Shock—Rivastigmine—Alzheimer's disease	0.000679	0.00164	CcSEcCtD
Vardenafil—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000677	0.00163	CcSEcCtD
Vardenafil—Tachycardia—Rivastigmine—Alzheimer's disease	0.000674	0.00163	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000671	0.00162	CcSEcCtD
Vardenafil—Skin disorder—Rivastigmine—Alzheimer's disease	0.00067	0.00162	CcSEcCtD
Vardenafil—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000667	0.00161	CcSEcCtD
Vardenafil—Pain—Donepezil—Alzheimer's disease	0.000665	0.0016	CcSEcCtD
Vardenafil—Dizziness—Galantamine—Alzheimer's disease	0.000663	0.0016	CcSEcCtD
Vardenafil—Hypotension—Memantine—Alzheimer's disease	0.000659	0.00159	CcSEcCtD
Vardenafil—Hypotension—Rivastigmine—Alzheimer's disease	0.000645	0.00156	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000643	0.00155	CcSEcCtD
Vardenafil—Feeling abnormal—Donepezil—Alzheimer's disease	0.00064	0.00154	CcSEcCtD
Vardenafil—Insomnia—Memantine—Alzheimer's disease	0.000638	0.00154	CcSEcCtD
Vardenafil—Vomiting—Galantamine—Alzheimer's disease	0.000638	0.00154	CcSEcCtD
Vardenafil—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000635	0.00153	CcSEcCtD
Vardenafil—Paraesthesia—Memantine—Alzheimer's disease	0.000634	0.00153	CcSEcCtD
Vardenafil—Rash—Galantamine—Alzheimer's disease	0.000632	0.00153	CcSEcCtD
Vardenafil—Dermatitis—Galantamine—Alzheimer's disease	0.000632	0.00152	CcSEcCtD
Vardenafil—Dyspnoea—Memantine—Alzheimer's disease	0.000629	0.00152	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000629	0.00152	CcSEcCtD
Vardenafil—Headache—Galantamine—Alzheimer's disease	0.000628	0.00152	CcSEcCtD
Vardenafil—Somnolence—Memantine—Alzheimer's disease	0.000627	0.00151	CcSEcCtD
Vardenafil—Insomnia—Rivastigmine—Alzheimer's disease	0.000624	0.00151	CcSEcCtD
Vardenafil—Dyspepsia—Memantine—Alzheimer's disease	0.000621	0.0015	CcSEcCtD
Vardenafil—Paraesthesia—Rivastigmine—Alzheimer's disease	0.00062	0.0015	CcSEcCtD
Vardenafil—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000615	0.00148	CcSEcCtD
Vardenafil—Abdominal pain—Donepezil—Alzheimer's disease	0.000614	0.00148	CcSEcCtD
Vardenafil—Somnolence—Rivastigmine—Alzheimer's disease	0.000614	0.00148	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000609	0.00147	CcSEcCtD
Vardenafil—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000608	0.00147	CcSEcCtD
Vardenafil—Pain—Memantine—Alzheimer's disease	0.000603	0.00146	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000596	0.00144	CcSEcCtD
Vardenafil—Nausea—Galantamine—Alzheimer's disease	0.000596	0.00144	CcSEcCtD
Vardenafil—Pain—Rivastigmine—Alzheimer's disease	0.00059	0.00142	CcSEcCtD
Vardenafil—Feeling abnormal—Memantine—Alzheimer's disease	0.000581	0.0014	CcSEcCtD
Vardenafil—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000577	0.00139	CcSEcCtD
Vardenafil—Hypersensitivity—Donepezil—Alzheimer's disease	0.000573	0.00138	CcSEcCtD
Vardenafil—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000569	0.00137	CcSEcCtD
Vardenafil—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000564	0.00136	CcSEcCtD
Vardenafil—Abdominal pain—Memantine—Alzheimer's disease	0.000558	0.00135	CcSEcCtD
Vardenafil—Asthenia—Donepezil—Alzheimer's disease	0.000558	0.00135	CcSEcCtD
Vardenafil—Pruritus—Donepezil—Alzheimer's disease	0.00055	0.00133	CcSEcCtD
Vardenafil—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000546	0.00132	CcSEcCtD
Vardenafil—Diarrhoea—Donepezil—Alzheimer's disease	0.000532	0.00128	CcSEcCtD
Vardenafil—Hypersensitivity—Memantine—Alzheimer's disease	0.00052	0.00125	CcSEcCtD
Vardenafil—Dizziness—Donepezil—Alzheimer's disease	0.000514	0.00124	CcSEcCtD
Vardenafil—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000509	0.00123	CcSEcCtD
Vardenafil—Asthenia—Memantine—Alzheimer's disease	0.000506	0.00122	CcSEcCtD
Vardenafil—Pruritus—Memantine—Alzheimer's disease	0.000499	0.0012	CcSEcCtD
Vardenafil—Asthenia—Rivastigmine—Alzheimer's disease	0.000495	0.00119	CcSEcCtD
Vardenafil—Vomiting—Donepezil—Alzheimer's disease	0.000494	0.00119	CcSEcCtD
Vardenafil—Rash—Donepezil—Alzheimer's disease	0.00049	0.00118	CcSEcCtD
Vardenafil—Dermatitis—Donepezil—Alzheimer's disease	0.00049	0.00118	CcSEcCtD
Vardenafil—Pruritus—Rivastigmine—Alzheimer's disease	0.000488	0.00118	CcSEcCtD
Vardenafil—Headache—Donepezil—Alzheimer's disease	0.000487	0.00117	CcSEcCtD
Vardenafil—Diarrhoea—Memantine—Alzheimer's disease	0.000483	0.00116	CcSEcCtD
Vardenafil—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000472	0.00114	CcSEcCtD
Vardenafil—Dizziness—Memantine—Alzheimer's disease	0.000467	0.00113	CcSEcCtD
Vardenafil—Nausea—Donepezil—Alzheimer's disease	0.000462	0.00111	CcSEcCtD
Vardenafil—Dizziness—Rivastigmine—Alzheimer's disease	0.000456	0.0011	CcSEcCtD
Vardenafil—Vomiting—Memantine—Alzheimer's disease	0.000449	0.00108	CcSEcCtD
Vardenafil—Rash—Memantine—Alzheimer's disease	0.000445	0.00107	CcSEcCtD
Vardenafil—Dermatitis—Memantine—Alzheimer's disease	0.000444	0.00107	CcSEcCtD
Vardenafil—Headache—Memantine—Alzheimer's disease	0.000442	0.00107	CcSEcCtD
Vardenafil—Vomiting—Rivastigmine—Alzheimer's disease	0.000439	0.00106	CcSEcCtD
Vardenafil—Rash—Rivastigmine—Alzheimer's disease	0.000435	0.00105	CcSEcCtD
Vardenafil—Dermatitis—Rivastigmine—Alzheimer's disease	0.000435	0.00105	CcSEcCtD
Vardenafil—Headache—Rivastigmine—Alzheimer's disease	0.000432	0.00104	CcSEcCtD
Vardenafil—Nausea—Memantine—Alzheimer's disease	0.000419	0.00101	CcSEcCtD
Vardenafil—Nausea—Rivastigmine—Alzheimer's disease	0.00041	0.000989	CcSEcCtD
Vardenafil—PDE6G—Signaling Pathways—NGF—Alzheimer's disease	7.79e-05	0.00036	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—CREB1—Alzheimer's disease	7.76e-05	0.000359	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	7.73e-05	0.000358	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—IL6—Alzheimer's disease	7.69e-05	0.000356	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GAPDHS—Alzheimer's disease	7.68e-05	0.000355	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—AKT1—Alzheimer's disease	7.65e-05	0.000354	CbGpPWpGaD
Vardenafil—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	7.62e-05	0.000353	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—NGF—Alzheimer's disease	7.59e-05	0.000351	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CCR5—Alzheimer's disease	7.57e-05	0.000351	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CALM1—Alzheimer's disease	7.56e-05	0.00035	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—APOE—Alzheimer's disease	7.53e-05	0.000349	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—LEP—Alzheimer's disease	7.53e-05	0.000349	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—NOS3—Alzheimer's disease	7.52e-05	0.000348	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—A2M—Alzheimer's disease	7.46e-05	0.000346	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CAV1—Alzheimer's disease	7.46e-05	0.000346	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—HTR2A—Alzheimer's disease	7.41e-05	0.000343	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CCR5—Alzheimer's disease	7.38e-05	0.000342	CbGpPWpGaD
Vardenafil—PDE6G—Disease—NOS3—Alzheimer's disease	7.37e-05	0.000341	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—PRKCG—Alzheimer's disease	7.36e-05	0.000341	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ATP5A1—Alzheimer's disease	7.28e-05	0.000337	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PSEN2—Alzheimer's disease	7.23e-05	0.000335	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—HTR2A—Alzheimer's disease	7.22e-05	0.000334	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—ESR1—Alzheimer's disease	7.19e-05	0.000333	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—S100B—Alzheimer's disease	7.12e-05	0.000329	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—F2—Alzheimer's disease	7.1e-05	0.000329	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—AKT1—Alzheimer's disease	7.09e-05	0.000328	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—CCR5—Alzheimer's disease	6.97e-05	0.000323	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—NOTCH1—Alzheimer's disease	6.95e-05	0.000322	CbGpPWpGaD
Vardenafil—PDE1B—Disease—ADAM10—Alzheimer's disease	6.95e-05	0.000322	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PLD3—Alzheimer's disease	6.94e-05	0.000321	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CALM1—Alzheimer's disease	6.92e-05	0.00032	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—APOE—Alzheimer's disease	6.89e-05	0.000319	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—LEP—Alzheimer's disease	6.89e-05	0.000319	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CAV1—Alzheimer's disease	6.83e-05	0.000316	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—HTR2A—Alzheimer's disease	6.82e-05	0.000316	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—AKT1—Alzheimer's disease	6.82e-05	0.000316	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—AKT1—Alzheimer's disease	6.82e-05	0.000316	CbGpPWpGaD
Vardenafil—PDE6G—Disease—PTGS2—Alzheimer's disease	6.74e-05	0.000312	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CALM1—Alzheimer's disease	6.74e-05	0.000312	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—APOE—Alzheimer's disease	6.72e-05	0.000311	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—LEP—Alzheimer's disease	6.72e-05	0.000311	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—PRKCG—Alzheimer's disease	6.68e-05	0.000309	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—HSD17B10—Alzheimer's disease	6.66e-05	0.000308	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NPY—Alzheimer's disease	6.65e-05	0.000308	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CAV1—Alzheimer's disease	6.65e-05	0.000308	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IAPP—Alzheimer's disease	6.61e-05	0.000306	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—ESR1—Alzheimer's disease	6.58e-05	0.000305	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—GSK3B—Alzheimer's disease	6.52e-05	0.000302	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—BCL2—Alzheimer's disease	6.52e-05	0.000302	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—F2—Alzheimer's disease	6.5e-05	0.000301	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CREB1—Alzheimer's disease	6.47e-05	0.0003	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—INS—Alzheimer's disease	6.44e-05	0.000298	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL1A—Alzheimer's disease	6.43e-05	0.000298	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CRH—Alzheimer's disease	6.42e-05	0.000297	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—ESR1—Alzheimer's disease	6.41e-05	0.000297	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP46A1—Alzheimer's disease	6.41e-05	0.000297	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—NOTCH1—Alzheimer's disease	6.36e-05	0.000294	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CCL2—Alzheimer's disease	6.33e-05	0.000293	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—F2—Alzheimer's disease	6.33e-05	0.000293	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CCR5—Alzheimer's disease	6.33e-05	0.000293	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IGF1—Alzheimer's disease	6.23e-05	0.000288	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—MEF2C—Alzheimer's disease	6.22e-05	0.000288	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—NOTCH1—Alzheimer's disease	6.2e-05	0.000287	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—HTR2A—Alzheimer's disease	6.2e-05	0.000287	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ND1—Alzheimer's disease	6.19e-05	0.000286	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—AGER—Alzheimer's disease	6.17e-05	0.000286	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PRKCG—Alzheimer's disease	6.11e-05	0.000283	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NPS—Alzheimer's disease	6.09e-05	0.000282	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PPP3CA—Alzheimer's disease	6.06e-05	0.00028	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—F2—Alzheimer's disease	5.98e-05	0.000277	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PTK2B—Alzheimer's disease	5.97e-05	0.000276	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—GSK3B—Alzheimer's disease	5.97e-05	0.000276	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CREB1—Alzheimer's disease	5.92e-05	0.000274	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—IL6—Alzheimer's disease	5.91e-05	0.000274	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—INS—Alzheimer's disease	5.89e-05	0.000272	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—GSK3B—Alzheimer's disease	5.82e-05	0.000269	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NTRK2—Alzheimer's disease	5.81e-05	0.000269	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—GAB2—Alzheimer's disease	5.81e-05	0.000269	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SST—Alzheimer's disease	5.81e-05	0.000269	CbGpPWpGaD
Vardenafil—PDE1B—Disease—LPL—Alzheimer's disease	5.8e-05	0.000268	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CCL2—Alzheimer's disease	5.79e-05	0.000268	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CALM1—Alzheimer's disease	5.78e-05	0.000268	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CREB1—Alzheimer's disease	5.77e-05	0.000267	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—GSK3A—Alzheimer's disease	5.75e-05	0.000266	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—INS—Alzheimer's disease	5.74e-05	0.000266	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IGF1—Alzheimer's disease	5.69e-05	0.000264	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—APP—Alzheimer's disease	5.66e-05	0.000262	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—NOS3—Alzheimer's disease	5.64e-05	0.000261	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CCL2—Alzheimer's disease	5.64e-05	0.000261	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PRKCG—Alzheimer's disease	5.64e-05	0.000261	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IGF1—Alzheimer's disease	5.55e-05	0.000257	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—AKT1—Alzheimer's disease	5.46e-05	0.000253	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—F2—Alzheimer's disease	5.43e-05	0.000251	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—VEGFA—Alzheimer's disease	5.42e-05	0.000251	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CCR5—Alzheimer's disease	5.34e-05	0.000247	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PLCB1—Alzheimer's disease	5.34e-05	0.000247	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—MAPK8—Alzheimer's disease	5.28e-05	0.000245	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CALM1—Alzheimer's disease	5.28e-05	0.000245	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MTHFR—Alzheimer's disease	5.22e-05	0.000242	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—NOS3—Alzheimer's disease	5.16e-05	0.000239	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—NOS3—Alzheimer's disease	5.03e-05	0.000233	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NGFR—Alzheimer's disease	4.98e-05	0.000231	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—TGFB1—Alzheimer's disease	4.97e-05	0.00023	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CREB1—Alzheimer's disease	4.95e-05	0.000229	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CALM1—Alzheimer's disease	4.88e-05	0.000226	CbGpPWpGaD
Vardenafil—PDE6G—Disease—TGFB1—Alzheimer's disease	4.87e-05	0.000226	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ADAM10—Alzheimer's disease	4.86e-05	0.000225	CbGpPWpGaD
Vardenafil—PDE1B—Disease—APOE—Alzheimer's disease	4.86e-05	0.000225	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CCL2—Alzheimer's disease	4.84e-05	0.000224	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—AKT1—Alzheimer's disease	4.84e-05	0.000224	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CAV1—Alzheimer's disease	4.82e-05	0.000223	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CASP3—Alzheimer's disease	4.79e-05	0.000222	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—IL6—Alzheimer's disease	4.76e-05	0.00022	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—S100B—Alzheimer's disease	4.6e-05	0.000213	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—GSK3B—Alzheimer's disease	4.56e-05	0.000211	CbGpPWpGaD
Vardenafil—PDE1B—Disease—NOS2—Alzheimer's disease	4.53e-05	0.00021	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CREB1—Alzheimer's disease	4.52e-05	0.000209	CbGpPWpGaD
Vardenafil—PDE1B—Disease—NOTCH1—Alzheimer's disease	4.49e-05	0.000208	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	4.47e-05	0.000207	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MAPK8—Alzheimer's disease	4.4e-05	0.000204	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—AKT1—Alzheimer's disease	4.39e-05	0.000203	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CASP3—Alzheimer's disease	4.38e-05	0.000203	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IGF2—Alzheimer's disease	4.38e-05	0.000203	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—AKT1—Alzheimer's disease	4.31e-05	0.0002	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CASP3—Alzheimer's disease	4.27e-05	0.000198	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—IL6—Alzheimer's disease	4.24e-05	0.000196	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IGF1R—Alzheimer's disease	4.23e-05	0.000196	CbGpPWpGaD
Vardenafil—PDE1B—Disease—GSK3B—Alzheimer's disease	4.21e-05	0.000195	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CREB1—Alzheimer's disease	4.17e-05	0.000193	CbGpPWpGaD
Vardenafil—PDE1B—Disease—INS—Alzheimer's disease	4.15e-05	0.000192	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—TP53—Alzheimer's disease	4.09e-05	0.000189	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—VEGFA—Alzheimer's disease	4.07e-05	0.000188	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—LPL—Alzheimer's disease	4.06e-05	0.000188	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MAPK8—Alzheimer's disease	4.03e-05	0.000186	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MEF2C—Alzheimer's disease	4.02e-05	0.000186	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CHAT—Alzheimer's disease	3.99e-05	0.000185	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—TPI1—Alzheimer's disease	3.99e-05	0.000185	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PRKCG—Alzheimer's disease	3.95e-05	0.000183	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MAPK8—Alzheimer's disease	3.93e-05	0.000182	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—AKT1—Alzheimer's disease	3.91e-05	0.000181	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NGF—Alzheimer's disease	3.85e-05	0.000178	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—MAOB—Alzheimer's disease	3.82e-05	0.000177	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CA4—Alzheimer's disease	3.8e-05	0.000176	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—BCL2—Alzheimer's disease	3.8e-05	0.000176	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCR5—Alzheimer's disease	3.74e-05	0.000173	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TGFB1—Alzheimer's disease	3.73e-05	0.000173	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—VEGFA—Alzheimer's disease	3.72e-05	0.000172	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GAPDH—Alzheimer's disease	3.68e-05	0.00017	CbGpPWpGaD
Vardenafil—PDE6G—Disease—IL6—Alzheimer's disease	3.67e-05	0.00017	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HTR2A—Alzheimer's disease	3.66e-05	0.000169	CbGpPWpGaD
Vardenafil—PDE1B—Disease—NOS3—Alzheimer's disease	3.64e-05	0.000169	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—VEGFA—Alzheimer's disease	3.62e-05	0.000168	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	3.57e-05	0.000165	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—A2M—Alzheimer's disease	3.55e-05	0.000165	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—AKT1—Alzheimer's disease	3.46e-05	0.00016	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CALM1—Alzheimer's disease	3.42e-05	0.000158	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TGFB1—Alzheimer's disease	3.41e-05	0.000158	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—LEP—Alzheimer's disease	3.4e-05	0.000158	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—APOE—Alzheimer's disease	3.4e-05	0.000158	CbGpPWpGaD
Vardenafil—PDE6G—Disease—AKT1—Alzheimer's disease	3.39e-05	0.000157	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	3.38e-05	0.000157	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—IL6—Alzheimer's disease	3.37e-05	0.000156	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CAV1—Alzheimer's disease	3.37e-05	0.000156	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL1B—Alzheimer's disease	3.36e-05	0.000155	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PTGS2—Alzheimer's disease	3.33e-05	0.000154	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TGFB1—Alzheimer's disease	3.33e-05	0.000154	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ESR1—Alzheimer's disease	3.25e-05	0.00015	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PLD3—Alzheimer's disease	3.23e-05	0.000149	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—F2—Alzheimer's disease	3.21e-05	0.000149	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NOTCH1—Alzheimer's disease	3.14e-05	0.000145	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—AKT1—Alzheimer's disease	3.11e-05	0.000144	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	3.1e-05	0.000143	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ACHE—Alzheimer's disease	3.09e-05	0.000143	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—MAPK8—Alzheimer's disease	3.08e-05	0.000142	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TP53—Alzheimer's disease	3.07e-05	0.000142	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—INPP5D—Alzheimer's disease	3.06e-05	0.000141	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	2.98e-05	0.000138	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—GSK3B—Alzheimer's disease	2.95e-05	0.000136	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CREB1—Alzheimer's disease	2.92e-05	0.000135	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—INS—Alzheimer's disease	2.91e-05	0.000135	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ENO1—Alzheimer's disease	2.9e-05	0.000134	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PTGS1—Alzheimer's disease	2.9e-05	0.000134	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ND1—Alzheimer's disease	2.88e-05	0.000133	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCL2—Alzheimer's disease	2.86e-05	0.000132	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP2D6—Alzheimer's disease	2.84e-05	0.000132	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IL6—Alzheimer's disease	2.81e-05	0.00013	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IGF1—Alzheimer's disease	2.81e-05	0.00013	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TP53—Alzheimer's disease	2.81e-05	0.00013	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TP53—Alzheimer's disease	2.74e-05	0.000127	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—BCHE—Alzheimer's disease	2.69e-05	0.000125	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—AKT1—Alzheimer's disease	2.59e-05	0.00012	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IL6—Alzheimer's disease	2.57e-05	0.000119	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NOS3—Alzheimer's disease	2.55e-05	0.000118	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PLCB1—Alzheimer's disease	2.54e-05	0.000118	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IL6—Alzheimer's disease	2.51e-05	0.000116	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ABCA1—Alzheimer's disease	2.46e-05	0.000114	CbGpPWpGaD
Vardenafil—PDE1B—Disease—TGFB1—Alzheimer's disease	2.41e-05	0.000111	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—AKT1—Alzheimer's disease	2.37e-05	0.00011	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—AKT1—Alzheimer's disease	2.31e-05	0.000107	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—AKT1—Alzheimer's disease	2.18e-05	0.000101	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CASP3—Alzheimer's disease	2.16e-05	0.0001	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—IL6—Alzheimer's disease	2.15e-05	9.95e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PPARGC1A—Alzheimer's disease	2.12e-05	9.83e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—HMOX1—Alzheimer's disease	2.11e-05	9.78e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MAPK8—Alzheimer's disease	1.99e-05	9.21e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—AKT1—Alzheimer's disease	1.98e-05	9.18e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL6—Alzheimer's disease	1.96e-05	9.09e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—LPL—Alzheimer's disease	1.93e-05	8.95e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.85e-05	8.58e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.85e-05	8.58e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—VEGFA—Alzheimer's disease	1.84e-05	8.5e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—IL6—Alzheimer's disease	1.81e-05	8.4e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—AKT1—Alzheimer's disease	1.81e-05	8.39e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.78e-05	8.23e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	1.74e-05	8.06e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.71e-05	7.92e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TGFB1—Alzheimer's disease	1.69e-05	7.8e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—AKT1—Alzheimer's disease	1.67e-05	7.75e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.65e-05	7.65e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CALM1—Alzheimer's disease	1.63e-05	7.53e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—APOE—Alzheimer's disease	1.62e-05	7.5e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CAV1—Alzheimer's disease	1.61e-05	7.43e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.44e-05	6.65e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.42e-05	6.58e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PPARG—Alzheimer's disease	1.41e-05	6.53e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TP53—Alzheimer's disease	1.39e-05	6.42e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—INS—Alzheimer's disease	1.38e-05	6.41e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.35e-05	6.24e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.35e-05	6.24e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.32e-05	6.12e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IL6—Alzheimer's disease	1.27e-05	5.88e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.25e-05	5.8e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—NOS3—Alzheimer's disease	1.21e-05	5.62e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.18e-05	5.47e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AKT1—Alzheimer's disease	1.17e-05	5.42e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.15e-05	5.3e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	1.11e-05	5.14e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	9.87e-06	4.57e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	9.83e-06	4.55e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—LPL—Alzheimer's disease	8.99e-06	4.16e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	8.09e-06	3.75e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CALM1—Alzheimer's disease	7.56e-06	3.5e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—APOE—Alzheimer's disease	7.53e-06	3.49e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CAV1—Alzheimer's disease	7.47e-06	3.46e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PPARG—Alzheimer's disease	6.56e-06	3.04e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—INS—Alzheimer's disease	6.44e-06	2.98e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NOS3—Alzheimer's disease	5.64e-06	2.61e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—AKT1—Alzheimer's disease	5.58e-06	2.58e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	5.16e-06	2.39e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—AKT1—Alzheimer's disease	2.59e-06	1.2e-05	CbGpPWpGaD
